Keyphrases
Pharmacokinetic Properties
100%
Aggregation Inhibitor
100%
Transthyretin
100%
High Affinity
100%
Clinical Trials
28%
Rational Design
14%
Wild-type Transthyretin
14%
Chemical Chaperone
14%
Disease-modifying Therapy
14%
Oral Bioavailability
14%
Molecular Dynamics Simulation
14%
Tolcapone
14%
Disease-associated
14%
Transthyretin Amyloidosis
14%
Prevalent Diseases
14%
Kinetic Stabilizer
14%
Genetic Type
14%
Dissociation
14%
Structural Optimization
14%
Pharmacokinetic Study
14%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetic Properties
100%
Transthyretin
100%
Clinical Trial
22%
Wild Type
22%
Genetics
11%
Chemical Chaperone
11%
Pharmacokinetics
11%
Amyloidosis
11%
Computer Simulation
11%
Blood Plasma
11%